Arixtra Related Clinical Trials
ARIXTRA Local Study For Registration In China. [Completed]
Study of Arixtra to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy [Terminated]
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer [Completed]
Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism [Completed]
Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression [Withdrawn]
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism [Terminated]
Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) [Terminated]
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients [Completed]
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology) [Completed]
Fondaparinux in Critically Ill Patients With Renal Failure [Completed]
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis [Completed]
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure. [Terminated]
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery [Completed]
Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT) [Withdrawn]
Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients [Terminated]
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients [Terminated]
The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty [Not yet recruiting]
Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency [Terminated]
Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux [Recruiting]
Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia [Recruiting]
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers [Completed]
Fondaparinux EU-RMP (Adherence) [Completed]
A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients [Completed]
ARIXTRA® Adherence in SVT Patients. [Completed]
Special Drug Use Investigation (Retrospective) for Arixtra� (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) [Completed]
Hemorrhage Risk Prescribed Arixtra [Completed]
Study to Determine Effective Dosing of Fondaparinux in Obese Persons [Terminated]
"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" [Completed]
Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction [Withdrawn]
Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux. [Completed]
Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy [Withdrawn]
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery [Completed]
Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO) [Completed]
Special Drug Use Investigation for Arixtra� (Fondaparinux) Venous Thromboembolism Treatment [Completed]
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer [Completed]
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis [Active, not recruiting]
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery [Completed]
Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication [Not yet recruiting]
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Completed]
The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Completed]
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) [Completed]
Fondaparinux Population Pharmacokinetic to Morbid Obese Patients in Post-operatory Bariatric Surgery [Completed]
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients [Completed]
Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures [Recruiting]
Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI [Completed]
Michelangelo - Oasis 5 [Completed]
Special Drug Use Investigation for ARIXTRA� (Fondaparinux) Injection [Completed]
Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study [Not yet recruiting]
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism [Completed]
Pharmacokinetics of Fondaparinux in Patients With Major Orthopedic Surgery [Completed]
Hip Fracture Study of GSK576428 (Fondaparinux Sodium) [Completed]
Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II [Completed]
Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux [Terminated]
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty [Completed]
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery [Completed]
Determination of Residual Anticoagulatory Effects of Fondaparinux [Recruiting]
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN) [Withdrawn]
Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery [Active, not recruiting]
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients [Recruiting]
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs [Completed]
Registry of Hospitalized Patients Treated With Fondaparinux [Completed]
Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study [Completed]
Xarelto Regulatory Post-Marketing Surveillance [Completed]
EINSTEIN Junior Phase III: Oral Rivaroxaban in Children With Venous Thrombosis [Recruiting]
START-Register: Survey on Anticoagulated Patients Register [Recruiting]
Tranexamic Acid in HIp Fracture Surgery (THIF Study) [Completed]
PENELOPE Observational Study [Withdrawn]
Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism [Recruiting]
Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin [Completed]
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE [Recruiting]
Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients [Recruiting]
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy [Completed]
Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy [Recruiting]
Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction [Completed]
Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin. [Recruiting]
|